![](/img/cover-not-exists.png)
GCG100649, A Novel Cyclooxygenase-2 Inhibitor, Exhibits a Drug Disposition Profile in Healthy Volunteers Compatible With High Affinity to Carbonic Anhydrase-I/II: Preliminary Dose-Exposure Relationships to Define Clinical Development Strategies
Hirankarn, Sarapee, Barrett, Jeffrey S., Alamuddin, Naji, FitzGerald, Garret A., Skarke, CarstenVolume:
2
Language:
english
Journal:
Clinical Pharmacology in Drug Development
DOI:
10.1002/cpdd.47
Date:
October, 2013
File:
PDF, 1.33 MB
english, 2013